NEWS
NORMAN, OKLA. – The world’s largest society for radiation oncology professionals recently voted to confer upon Jerry Jaboin M.D., Ph.D., M.B.A., the chair of the Department of Radiation Oncology at the University of Oklahoma’s College of Medicine, the designation of Fellow of the American Society for Radiation Oncology (FASTRO). Jaboin will receive the FASTRO designation at an awards ceremony in Washington, D.C., on Tuesday, October 1, during ASTRO’s 66th Annual Meeting.
Jaboin mentioned his gratefulness for being recognized as a peer to a distinguished society. The recognition, he feels, can accelerate other opportunities for national and international visibility. His work has been heightened by working at the Stephenson Cancer Center due to its reputation for being “pound for pound the number one clinical trials institution in the country.”
“What this affords me is the ability to sponsor other like-minded faculty and trainees’ greater access to opportunities within ASTRO,” said Jaboin. “It is a true pleasure to be a member of this team”
Awarded annually since 2006, the ASTRO Fellows program recognizes individuals who have made significant contributions to radiation oncology through research, education, patient care and service to the field. Since its inception, the FASTRO designation has been awarded to just 498 of ASTRO’s 10,000 members worldwide. The 2024 class is the largest since the inaugural Fellows were named nearly two decades ago.
“Dr. Jaboin, a physician at OU’s Stephenson Cancer Center, joins an elite group of just 48 physicians and medical physicists who are recognized this year for their far-reaching contributions to the field of radiation oncology and their progress in advancing cancer research, education, and patient care,” said Jeff M. Michalski, M.D., M.B.A. and chair of the ASTRO Board of Directors. “Congratulations to Dr. Jaboin for achieving the designation of ASTRO Fellow.”
Jaboin completed his graduate work as one of the inaugural students within the NIH Graduate Partnerships Program as an individual member of Howard University from 1996 until 2004. He then worked as a radiation oncology resident, and American Board of Radiology Holman Fellow at Vanderbilt University from 2006-10. Before arriving at OU Health Sciences in Nov. 2021, he was a professor and vice chair of the Department of Radiation Medicine at Oregon Health and Science University in Portland.
“Dr. Jerry Jaboin's recognition as a Fellow of the American Society for Radiation Oncology is a testament to his exceptional dedication and expertise in the field of radiation oncology,” said Ian F. Dunn, MD, FACS, FAANS, executive dean for the OU College of Medicine. “This prestigious honor not only highlights Dr. Jaboin's significant contributions to cancer care and research but also underscores the caliber of faculty at the OU College of Medicine.
“We are proud to have such distinguished professionals leading the way in advancing medical science and patient care,” continued Dunn.”
More information about the Fellows program is available via the ASTRO website, including the complete list of ASTRO Fellows and information about the nomination and selection process.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. OU was named the state’s highest-ranking university in U.S. News & World Report’s most recent Best Colleges list. For more information about the university, visit ou.edu.
The University of Oklahoma Honors College hosted its 38th annual Undergraduate Research Day on April 16 in the Thurman J. White Forum Building. Over 300 people attended, and 175 students presented their posters and projects to visitors, faculty members, judges and peers.
The Collaborative Doctor of Education (Ed.D.) in Educational Leadership offers emerging leaders across Oklahoma’s PK–12 public education system a doctoral experience designed to be as relevant as it is rigorous.
A study published today in PLOS Medicine has identified two new genetic pathways that contribute to cardiometabolic disease, which includes heart disease, obesity and diabetes. The research, led by Dharambir Sanghera, Ph.D., of the University of Oklahoma, represents a step toward targeting the diseases more precisely.
